News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
07/01/2009

Remains on track for planned spinoff later this summer

SAN DIEGO, July 1, 2009 — CareFusion Corporation, the company that will become public following the planned spinoff of Cardinal Health’s clinical and medical products businesses, today launched its new brand and marked the occasion by providing opportunities for its global employees to volunteer for non-profit organizations in their communities.

“This is an exciting day for our company and employees because we believe the opportunity we have to help hospitals measurably improve patient safety and the quality of patient care is of vital importance to the future of global health care,” said David Schlotterbeck, chief executive officer of CareFusion.  “We are focused on this opportunity as we develop proven medical technologies and combine them with the information our customers need to deliver a higher standard of patient care.”

CareFusion Launches Brand

CareFusion’s brand signifies the fusion of proven technologies with actionable intelligence to measurably improve care.  The company’s logo is in the shape of a shield to reflect the protection CareFusion provides to patients and clinicians.  The two pieces of the shield represent the “fusion” of technology and intelligence integral to the company’s mission, and the orange color was selected for its implication of “safety.”

An advertising campaign launched today uses simple, recognizable symbols in a bold presentation against the company’s signature orange color to highlight the value CareFusion brings to its customers.  The print advertisements will appear more broadly in health care trade journals and national media beginning July 15.

CareFusion “Day of Caring”

The CareFusion “Day of Caring” is designed to encourage its employees to help bring its new brand and culture to life by giving back to the communities where they live and work. Employees at more than 20 locations worldwide will volunteer to support local charitable organizations. Many locations will be participating in a Foundation for Hospital Art PaintFest®, where they will paint canvases that will be donated to local hospitals. Other non-profit organizations supported include local food banks, parks and health and human services agencies.

CareFusion Spinoff

CareFusion’s planned spinoff from Cardinal Health is expected to be completed later this summer.  Additional information regarding CareFusion and the planned spinoff can be found in the third amendment to its Form 10 registration statement filed with the U.S. Securities and Exchange Commission on June 26, 2009.


About CareFusion Corporation
CareFusion Corporation, a wholly owned subsidiary of Cardinal Health (NYSE:CAH), is expected to become a public company from the planned spinoff of Cardinal Health’s clinical and medical products businesses. The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of health care. CareFusion develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® and MedMined™ services for infection prevention, neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations and serves customers in 120 countries. The company has applied to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol “CFN.”  More information may be found at www.carefusion.com.

Cautions Concerning Forward-Looking Statements
This news release contains forward-looking statements addressing the planned spinoff of Cardinal Health’s clinical and medical products businesses as a separate company named CareFusion Corporation, which is dependent upon future events or developments.  These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied.  These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions.  In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion’s Form 10, as amended, and Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports.  Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

 

More Company News
11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

11/05/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on...

11/01/2024

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $568 million; GAAP...

View all company news »